| ADMET Descriptor | Level | Description |
| ADMET Absorption Level (Human Intestinal Absorption (HIA)) | 0 | Good absorption |
| 1 | Moderate absorption | |
| 2 | Low absorption | |
| 3 | Very low absorption | |
| ADMET Solubility Level (Aqueous Solubility Levels) | 0 | Extremely low |
| 1 | No, very low, but possible | |
| 2 | Yes, low | |
| 3 | Yes, good | |
| 4 | Yes, optimal | |
| 5 | No, too soluble | |
| 6 | Warning: molecules with one or more unknown AlogP98 types | |
| ADMET Blood Brain Barrier (BBB Penetration Levels) | 0 | Very High |
| 1 | High | |
| 2 | Medium | |
| 3 | Low | |
| 4 | Undefined | |
| 5 | Warning: molecules with one or more unknown AlogP98 types | |
| ADMET Cytochrome P450 2D6 (CYP2D6) Inhibition | 0 | Non-inhibitor |
| 1 | Inhibitor | |
| ADMET Hepatotoxicity | 0 | Non-hepatotoxic |
| 1 | Toxic | |
| ADMET PPB (Plasma Protein Binding) | 0 | Binding is <90% |
| 1 | Binding is ≥90% | |
| AMES Mutagenicity | 0 | Non-mutagen |
| 1 | Mutagen |